KAIST, IVI to collaborate on global vaccine research

Both sides will utilize KAIST's human immune response analysis tech platform in vaccine R&D

KAIST, IVI to collaborate on global vaccine research
Hae-Sung Lee 1
Nov 23, 2023 (Gmt+09:00) ihs@hankyung.com
Bio & Pharma

The Korea Advanced Institute of Science & Technology (KAIST) announced on Thursday that it signed a memorandum of understanding (MOU) with the International Vaccine Institute (IVI) for global vaccine research collaboration.

The two institutions will co-work on four projects: vaccine immune response analysis, joint research with global health partners, strengthening research and education in the fields of medicine and life sciences, and improving healthcare and vaccine accessibility in developing countries.

In particular, KAIST's accumulated human immune response analysis technology platform will be utilized for the vaccine immune response analysis project.

The goal is to expedite effective vaccine development by jointly undertaking immune response analysis for various vaccines currently under development by IVI, including the vaccine for the severe fever with thrombocytopenia syndrome virus, the hantavirus vaccine and the adenovirus vaccine.

The collaboration will extend to the analysis of cell immune responses at the molecular level, the discovery of biomarkers for vaccine immune responses and mutual cooperation in areas such as analysis technology education support.

"The global networking capabilities of IVI and the excellent research capabilities of KAIST will create synergies," IVI Director General Jerome Kim said. 

"This collaboration will enhance capabilities in the medical science fields such as vaccines and immunology and contribute to global health," KAIST President Kwang-Hyung Lee remarked.

Write to Hae-Sung Lee at ihs@hankyung.com

KAIST discovers diabetes treatment using light

KAIST discovers diabetes treatment using light

The Korea Advanced Institute of Science and Technology (KAIST) announced on Wednesday that they have discovered a method to treat diabetes by inserting organic light-emitting diodes (OLEDs) into the body. OLEDs emit light in the duodenal, increasing beneficial gut bacteria.A joint research tea

KAIST discloses Earth images from Next-Gen Small Sat 2

KAIST discloses Earth images from Next-Gen Small Sat 2

The radar image observed from next-generation small satellite 2 on Aug. 2. On the left is The World, an artificial island in the UAE, and on the right is Palm Jumeirah (Courtesy of KAIST) The main payload satellite Next-Generation Small Satellite 2" of the Nuri, launched on May 25, has been con

Hanwha Aerospace, KAIST to jointly develop off-road self-driving techs

Hanwha Aerospace, KAIST to jointly develop off-road self-driving techs

South Korea's Hanwha Aerospace Co. and the Korea Advanced Institute of Science and Technology (KAIST) have launched a joint project to develop off-road autonomous driving technology for military applications.This strategic initiative aims to proactively cultivate unmanned technology and in-hou

Team from KAIST wins Quadruped Robot Challenge of UK

Team from KAIST wins Quadruped Robot Challenge of UK

A team from the Korea Advanced Institute of Science and Technology (KAIST) has won the Quadruped Robot Challenge of the UK, easily beating models from the Massachusetts Institute of Technology (MIT) and Carnegie Mellon University of the US.South Korea's top tech school on Tuesday said Urban Ro

S.Korean Army opens Future & Innovation Research Center at KAIST

S.Korean Army opens Future & Innovation Research Center at KAIST

Chief of Staff of the Republic of Korea Army Park Jeong-Hwan (third from left) and  President of KAIST Kwang-Hyung Lee (fourth) South Korean army announced that the Korea Army Research Center for Future & Innovation, a defense-related advanced science and technology research institutio